摘要
药源性角膜病变主要是指药物尤其眼用药物制剂中药物本身及所含防腐剂的毒性,直接或间接导致角膜组织发生病理改变的疾病。由于其临床表现多样,缺乏特异性诊断标准,易造成误诊误治。中华医学会眼科学分会角膜病学组汇集相关领域专家,对药源性角膜病变诊治的关键技术进行梳理,形成共识性意见,以指导临床正确开展药源性角膜病变的防治工作。
Drug-induced keratopathy occurs when the use of certain drugs,particularly ophthalmic preparations,causes pathological changes in the cornea.These changes can be related to the toxic effects of the drugs themselves or drug preservatives.The disease is characterized by a range of clinical features and lacks specific diagnostic criteria,which can lead to misdiagnosis and inappropriate treatment.In order to address these challenges,the Cornea Group of the Ophthalmology Branch of the Chinese Medical Association has brought together leading experts in the field to review key techniques for the diagnosis and treatment of drug-induced keratopathy.As a result,they have developed this consensus to guide the prevention and treatment of this condition.
作者
中华医学会眼科学分会角膜病学组
史伟云
Cornea Group of Ophthalmology Branch of Chinese Medical Association;Shi Weiyun(不详;Eye Institute of Shandong First Medical University,Eye Hospital of Shandong First Medical University(Shandong Eye Hospital),State Key Laboratory Cultivation Base,Shandong Provincial Key Laboratory of Ophthalmology,School of Ophthalmology,Shandong First Medical University,Jinan 250021,China)
出处
《中华眼科杂志》
CAS
CSCD
北大核心
2023年第4期250-255,共6页
Chinese Journal of Ophthalmology
基金
国家自然科学基金(82271052,U20A20386)
山东省重点研发计划(2022CXGC010505)
山东省泰山学者青年专家计划(tsqn201909188)。
关键词
角膜疾病
药物相关性副作用和不良反应
眼药水
防腐剂
药物
诊疗准则(主题)
Corneal diseases
Drug-related side effects and adverse reactions
Ophthalmic solutions
Preservatives,pharmaceutical
Practice guidelines as topic
